PubMed Health⌕ Search

Biomedical subjects

V M Reznik

Publications and source records attributed to V M Reznik.

44 records · Page 3Linked to original sources
PubMed1981

Na and K dependence of the Na/K pump in cystic fibrosis fibroblasts.

The Na and K dependence of the Na/K pump was measured in skin fibroblasts from patients with cystic fibrosis and age/sex-matched controls. Under basal conditions, there was no difference between control and cystic fibrosis cells in protein per cell, intracellular Na and K content, or Na/K pump activity (measured as ouabain-sensitive 86Rb uptake). There was no difference in the Na dependence of the Na/K pump between cystic fibrosis cells and control cells. In cells from patients with cystic fibrosis, the Na/K pump had a significantly lower affinity for K (Km = 1.6 mM) when compared to normals (Km = 0.9 mM). This difference was demonstrated by using two independent experimental designs.

Adolescent↗
PubMed1980

Neo-Mull-Soy metabolic alkalosis: a model of Bartter's syndrome?

A case of Neo-Mull-Soy-induced metabolic alkalosis occurred in an 8-month-old child. This child had hypochloremic hypokalemic alkalosis as well as hyperreninemia. Initially, a diagnosis of Bartter's syndrome was made and treatment consisted of KCl replacement, indomethacin, and aspirin. In retrospect, the diagnosis of Neo-Mull-Soy induced metabolic alkalosis could have been suspected on the basis of the low chloride concentration in his urine. Proposed mechanisms for the etiology of Bartter's syndrome are reviewed. Neo-Mull-Soy induced metabolic alkalosis simulates Bartter's syndrome and supports the concept that the primary abnormality in Bartter's syndrome is chloride deficiency. The chloride deficiency in Bartter's syndrome results from a defect in active chloride transport in the thick ascending limb of the loop of Henle.

Alkalosis↗
PubMedDate not supplied

Transient hemiparesis associated with monoclonal CD3 antibody (OKT3) therapy.

OKT3 therapy for prevention or reversal of allograft rejection has been associated with a constellation of acute systemic side effects, defined as an OKT3 first-dose reaction. Specific neurologic syndromes, including aseptic meningitis and diffuse encephalitis, have also been observed. This report describes a 12-year-old girl with steroid-resistant renal allograft rejection who developed hemiparesis associated with initiation of OKT3 therapy.

Animals↗
PubMedDate not supplied

Prenatal diagnosis of severe urinary tract anomalies improves renal function and growth.

The clinical course of 14 children with bilateral renal disease diagnosed on prenatal ultrasound examination (prenatal group) was compared with a control group of 14 children who presented postnatally (postnatal group). The children in the prenatal group had earlier evaluation and treatment of their renal disease and fewer complications prior to diagnosis. Prenatally diagnosed children had a lower incidence of reduced renal function and better growth than matched controls.

Child, Preschool↗
PubMedDate not supplied

Used of a guide-wire inserted catheter for acute peritoneal dialysis.

Peritoneal dialysis was performed in 18 children using a new guide-wire inserted catheter technique. Catheter insertion was complicated only by mild bleeding in one patient. The catheters drained well immediately after insertion in 17 of the 18 patients. Catheters were used for an average of 6 days, with a range up to 16 days. Dialysate volumes could be increased quickly in most patients. Late complications were leakage (2), peritonitis (4) and obstruction (3). Leakage did not interfere with dialysis. The peritonitis episodes, which occurred between days 6 and 16 of dialysis, resolved satisfactorily with appropriate antibiotic therapy. The guide-wire catheter can be inserted and used for short term peritoneal dialysis in children.

Acute Kidney Injury↗
PubMedDate not supplied

Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome.

Phospholipid antibodies (lupus anticoagulant, cardiolipin) are associated with a syndrome of repeated fetal loss. Mothers with phospholipid antibodies are currently being treated with either prednisone, aspirin, or heparin to prevent fetal death. We describe a neonate whose mother had cardiolipin antibody and recurrent fetal loss and was treated with prednisone and aspirin. Thrombosis was noted in placental fetal vessels. Thromboses developed in the infant's aorta, left renal artery, middle cerebral artery, and superior sagittal sinus. Infants of phospholipid-positive mothers may have vascular thrombosis and should be carefully monitored for signs of thromboembolism.

Antiphospholipid Syndrome↗